
Bausch + Lomb (BLCO) | Stock Overview & Key Data
Bausch + Lomb Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $21.95 on June 26, 2023
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Bausch + Lomb BLCO | 4.15B Mid-cap | 4.09% | 16.86% | 27.27% | -22.57% | -22.22% | -13.36% | -11.42% | 129.78% |
Intuitive Surgical ISRG | 184.62B Large-cap | -1.99% | 0.22% | 15.22% | -3.07% | 0.62% | 20.39% | 153.51% | 146.51% |
Becton, Dickinson BDX | 48.64B Large-cap | -1.71% | 1.23% | -13.05% | -25.51% | -22.90% | -24.51% | -27.71% | -33.60% |
Avantor AVTR | 9.25B Mid-cap | -1.22% | 2.23% | -3.71% | -37.87% | -35.14% | -35.05% | -52.98% | -27.95% |
Repligen RGEN | 6.93B Mid-cap | 1.68% | -2.37% | 18.06% | -16.90% | -10.13% | -1.18% | -25.39% | -7.36% |
Stevanato STVN | 6.40B Mid-cap | -1.09% | 5.05% | 32.09% | 2.46% | 9.61% | 12.16% | 63.75% | 23.79% |
Ownership & Short Interest
Bausch + Lomb Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Bausch + Lomb would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
What is BLCO's 52-week high and low?
In the last 52 weeks, Bausch + Lomb reached a high of $21.69 (on October 14, 2024) and a low of $10.45 (on April 30, 2025).
What is the market cap and P/E ratio for BLCO?
Curious about Bausch + Lomb's size and valuation? Its market capitalization stands at 4.15B. When it comes to valuation, the P/E ratio (trailing twelve months) is -13.33, and the forward P/E (looking ahead) is 9.86.
Does BLCO pay dividends? If so, what's the yield?
As for dividends, Bausch + Lomb isn't currently offering a significant yield, or that specific data isn't available right now.
Who are Bausch + Lomb's main competitors or similar companies to consider before investing?
When looking at Bausch + Lomb, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company | Mkt Cap | Sector | Industry | 1Y Return | 3Y Return |
---|---|---|---|---|---|
Intuitive Surgical ISRG | 184.62B | Healthcare | Medical Instruments & Supplies | 20.39% | 153.51% |
Becton, Dickinson BDX | 48.64B | Healthcare | Medical Instruments & Supplies | -24.51% | -27.71% |
Avantor AVTR | 9.25B | Healthcare | Medical Instruments & Supplies | -35.05% | -52.98% |
Repligen RGEN | 6.93B | Healthcare | Medical Instruments & Supplies | -1.18% | -25.39% |
Stevanato STVN | 6.40B | Healthcare | Medical Instruments & Supplies | 12.16% | 63.75% |
For a more comprehensive list, please see the Peer Performance Comparison table on this page.
What are the key financial health indicators for Bausch + Lomb Corporation? (e.g., ROE, Debt/Equity)
To get a sense of Bausch + Lomb's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -5.36%, the Debt to Equity ratio from the most recent quarter is 75.07, and its Gross Profit Margin stands at 57.61%.
What is the recent revenue and earnings growth for BLCO?
Looking at Bausch + Lomb's growth, its revenue over the trailing twelve months (TTM) was $5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.50%, and quarterly earnings saw a YoY growth of 3.46%.
How much of BLCO stock is held by insiders and institutions?
Wondering who owns Bausch + Lomb stock? Company insiders (like executives and directors) hold about 88.17% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 11.01%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.